TigaTx

SenyaTx

This company develops antibody-based therapeutics targeting the LRG1 protein to treat patients with chronic vascular diseases, including nephrology, oncology, and ophthalmology conditions.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

Laigo Bio

This company develops bispecific antibody therapies that remove disease-causing membrane proteins to treat patients with cancer and autoimmune disorders.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Electra Therapeutics

Electra Therapeutics develops antibody therapies targeting signal regulatory proteins to treat patients with immunological diseases, cancer, and rare inflammatory conditions.

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.

Modulari-T Biosciences

This company develops modular immune receptors and delivery vehicles to create cell and gene therapies for patients with cancer and autoimmune diseases.